Trading Signals: BAX Stock Price Prediction and Forecast (Mon. Dec. 1, 2014 - Wed. Sep. 27, 2023)(Baxter International Inc.)
| BAX latest price $39.1500 (0.1%) ($38.8000 - $39.4100) on Thu. Sep. 14, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.67% (three month average) | RSI | 34 | Latest Price | $39.1500(0.1%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | BAX advances 0.1% a day on average for past five trading days. | Weekly Trend | BAX declines -3.6% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support BAX advance at 0% a week (0% probability) GDXJ(97%) XHB(97%) XRT(97%) XLF(95%) CEMB(93%) | Factors Impacting BAX price | BAX will decline at least -0.835% in a week (0% probabilities). OIH(-47%) VXX(-62%) UUP(-50%) TBT(-38%) USO(-33%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.835% (StdDev 1.67%) | Hourly BBV | 1.4 () | Intraday Trend | -0.4% | | | |
|
1 - 5 Day Possible Target | $32.67(-16.55%) | Resistance Level | $40.44 | 5 Day Moving Average | $38.79(0.93%) | 10 Day Moving Average | $39.24(-0.23%) | 20 Day Moving Average | $40.44(-3.19%) | To recent high | -20.6% | To recent low | 2.1% | Market Cap | $19.974b | | | | Baxter International, Inc. provides portfolio of essential renal and hospital products, including acute and chronic dialysis, sterile IV solutions, infusion systems and devices, parenteral nutrition therapies; premixed and oncolytic injectable, bio surgery products and anesthetics, drug reconstitution systems; and pharmacy automation, software and services. It operates through the following segment: Americas, Europe, Middle East & Africa and Asia-Pacific. The company was founded by Davis Baxter in 1931 and is headquartered in Deerfield, IL. |